help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Duffy, D. M.
Right arrow Articles by Stouffer, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Duffy, D. M.
Right arrow Articles by Stouffer, R. L.

Journal of Clinical Endocrinology & Metabolism, Vol 79, 1587-1594, Copyright © 1994 by Endocrine Society


ARTICLES

Acute administration of a 3 beta-hydroxysteroid dehydrogenase inhibitor to rhesus monkeys at the midluteal phase of the menstrual cycle: evidence for possible autocrine regulation of the primate corpus luteum by progesterone

DM Duffy, DL Hess and RL Stouffer
Division of Reproductive Sciences, Oregon Regional Primate Research Center, Beaverton 97006.

Colocalization of progesterone receptors and 3 beta-hydroxysteroid dehydrogenase (3 beta HSD), a key enzyme in progesterone biosynthesis, in macaque luteal cells suggest that progesterone has an autocrine role in the regulation of primate luteal function. To test this hypothesis, we administered trilostane, a 3 beta HSD inhibitor, to rhesus macaques at the midluteal phase of spontaneous menstrual cycles to rapidly and reversibly reduce progesterone production. Animals received trilostane (600 mg/dose; treated group; n = 5) or vehicle (control group; n = 4) orally on days 6-7 of the luteal phase. Trilostane significantly (P < 0.05) elevated pregnenolone levels within 1 h of treatment compared to those in vehicle-treated animals; after 1 day of treatment, the mean pregnenolone level (173 nmol/L) was 86-fold greater than the control value. Pregnenolone levels dropped after cessation of drug administration and became indistinguishable from control levels by day 13. Trilostane significantly reduced serum progesterone levels within 3 h of initial administration (P < 0.01), and levels remained near baseline (1.0 nmol/L) throughout the 2 days of treatment. Progesterone levels also remained low after cessation of trilostane treatment in four of five monkeys, and trilostane-treated animals experienced a shorter luteal phase than vehicle-treated animals (7.8 +/- 0.2 vs. 16 +/- 1 days; P < 0.01). Histological analysis (n = 3/group) revealed indexes of premature structural luteolysis by 4 days after the onset of trilostane administration. Exposure to trilostane had no effect on the percentage of luteal cells expressing progesterone receptors, as determined by immunocytochemistry. Serum LH levels were not different between treatment and control groups throughout the experimental period. As trilostane dramatically reduced serum progesterone and induced premature menses without major concurrent alteration in serum cortisol, we conclude that trilostane ios an effective, rapidly acting inhibitor of 3 beta HSD in the macaque corpus luteum during the midluteal phase of the menstrual cycle. Progesterone production did not typically resume after cessation of trilostane treatment despite continuing gonadotropin support luteolysis. Thus, progesterone or a related metabolite may be required to maintain the function and structural integrity of the primate corpus luteum during the normal menstrual cycle.


This article has been cited by other articles:


Home page
Endocr. Rev.Home page
J. Simard, M.-L. Ricketts, S. Gingras, P. Soucy, F. A. Feltus, and M. H. Melner
Molecular Biology of the 3{beta}-Hydroxysteroid Dehydrogenase/{Delta}5-{Delta}4 Isomerase Gene Family
Endocr. Rev., June 1, 2005; 26(4): 525 - 582.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
J. A Maybin and W C. Duncan
The human corpus luteum: which cells have progesterone receptors?
Reproduction, October 1, 2004; 128(4): 423 - 431.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
F. J. Diaz and M. C. Wiltbank
Acquisition of Luteolytic Capacity: Changes in Prostaglandin F2{alpha} Regulation of Steroid Hormone Receptors and Estradiol Biosynthesis in Pig Corpora Lutea
Biol Reprod, May 1, 2004; 70(5): 1333 - 1339.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
K. A. Young and R. L. Stouffer
Gonadotropin and Steroid Regulation of Matrix Metalloproteinases and Their Endogenous Tissue Inhibitors in the Developed Corpus Luteum of the Rhesus Monkey During the Menstrual Cycle
Biol Reprod, January 1, 2004; 70(1): 244 - 252.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
D. M. Duffy and R. L. Stouffer
Follicular administration of a cyclooxygenase inhibitor can prevent oocyte release without alteration of normal luteal function in rhesus monkeys
Hum. Reprod., November 1, 2002; 17(11): 2825 - 2831.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
K. Hosokawa, U. Ottander, P. Wahlberg, T. Ny, S. Cajander, and I.J. Olofsson
Dominant expression and distribution of oestrogen receptor {beta} over oestrogen receptor {{alpha}} in the human corpus luteum
Mol. Hum. Reprod., February 1, 2001; 7(2): 137 - 145.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
C. L. Chaffin and R. L. Stouffer
Role of gonadotrophins and progesterone in the regulation of morphological remodelling and atresia in the monkey peri-ovulatory follicle
Hum. Reprod., December 1, 2000; 15(12): 2489 - 2495.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
D. M. Duffy, C. L. Chaffin, and R. L. Stouffer
Expression of Estrogen Receptor {alpha} and {beta} in the Rhesus Monkey Corpus Luteum during the Menstrual Cycle: Regulation by Luteinizing Hormone and Progesterone
Endocrinology, May 1, 2000; 141(5): 1711 - 1717.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
B. R. Rueda, I. R. Hendry, W. J. Hendry III, F. Stormshak, O.D. Slayden, and J. S. Davis
Decreased Progesterone Levels and Progesterone Receptor Antagonists Promote Apoptotic Cell Death in Bovine Luteal Cells
Biol Reprod, February 1, 2000; 62(2): 269 - 276.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
C. L. Chaffin, R. L. Stouffer, and D. M. Duffy
Gonadotropin and Steroid Regulation of Steroid Receptor and Aryl Hydrocarbon Receptor Messenger Ribonucleic Acid in Macaque Granulosa Cells during the Periovulatory Interval
Endocrinology, October 1, 1999; 140(10): 4753 - 4760.
[Abstract] [Full Text]


Home page
Mol Hum ReprodHome page
W. C. Duncan, G. M. Cowen, and P. J. Illingworth
Steroidogenic enzyme expression in human corpora lutea in the presence and absence of exogenous human chorionic gonadotrophin (HCG)
Mol. Hum. Reprod., April 1, 1999; 5(4): 291 - 298.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. M. Duffy, D. R. Stewart, and R. L. Stouffer
Titrating Luteinizing Hormone Replacement to Sustain the Structure and Function of the Corpus Luteum after Gonadotropin-Releasing Hormone Antagonist Treatment in Rhesus Monkeys
J. Clin. Endocrinol. Metab., January 1, 1999; 84(1): 342 - 349.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Hild-Petito and A. T. Fazleabas
Expression of Steroid Receptors and Steroidogenic Enzymes in the Baboon (Papio anubis) Corpus Luteum during the Menstrual Cycle and Early Pregnancy
J. Clin. Endocrinol. Metab., March 1, 1997; 82(3): 955 - 962.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1994 by The Endocrine Society